MedicaidPrior AuthMedium impact
Policy Updates and Changes to Clinical Review Criteria pdf
Connecticut Medicaid (HUSKY Health)·CT · Endocrinology, Ophthalmology, Urology +2 more·Provider Bulletin
Effective date
Feb 1, 2023
We identified it
Jun 20, 2026
Summary
Connecticut Medicaid (CMAP) has issued new prior authorization requirements for Tepezza (teprotumumab-trbw) and updated clinical review criteria for continuous glucose monitors, incontinence supplies, and gender affirmation surgery, effective February 1, 2023. A new PA form for Tepezza will be available on the HUSKY Health website.
Action Required
By February 1, 2023: Billing team must obtain prior authorization for Tepezza (teprotumumab-trbw) prescriptions for Connecticut Medicaid patients. Download the new PA form from https://portal.ct.gov/husky under Information for Providers > Provider Forms. Review updated clinical review criteria for continuous glucose monitors, incontinence supplies, and gender affirmation surgery. Contact CHNCT at 1-800-440-5071 for prior authorization questions.